发明名称 |
METHOD FOR INHIBITING THROMBOSIS IN A PATIENT WHOSE BLOOD ISSUBJECTED TO EXTRACORPOREAL CIRCULATION |
摘要 |
This invention provides a method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal blood circulation which comprises contacting the extracorporeal circulating blood with a Factor IXa compound in an amount effective to inhibit thrombosis in the patient. The Factor IXa compound may include an active site-blocked Factor IXa compound or Glu-Gly-Arg chloromethyl ketone-inactivated human factor IXa compound. This invention also provides that the effective amount may be from about 0.1 .mu.g/ml plasma to about 250 .mu.g/ml plasma or from about 0.5 .mu.g/ml plasma to about 25 .mu.g/ml plasma. The patient may be subjected to extracorporeal blood circulation during transplant surgery or cardiopulmonary bypass surgery. This invention further provides for a pharmaceutical composition which includes an effective amount of a Factor IXa compound and a pharmaceutically acceptable carrier.
|
申请公布号 |
CA2255026(A1) |
申请公布日期 |
1997.11.20 |
申请号 |
CA19972255026 |
申请日期 |
1997.05.15 |
申请人 |
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
发明人 |
ROSE, ERIC;STERN, DAVID;SCHMIDT, ANN MARIE;SPANIER, TALIA |
分类号 |
A61K38/36;A61K38/48;A61M1/36;G01N33/86;(IPC1-7):A61K38/48;C12Q1/56 |
主分类号 |
A61K38/36 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|